Skip to main content

Articles

Page 2 of 2

  1. Asthma is a chronic inflammatory condition of the airways that affects roughly 358 million people globally. It is a serious global health problem with an increasing prevalence worldwide. Most people affected a...

    Authors: Asnakew Achaw Ayele and Henok Getachew Tegegn
    Citation: Asthma Research and Practice 2017 3:7
  2. Many studies have evaluated associations between asthma emergency department (ED) visits, hospital admissions (HAs), and ambient ozone (O3) across the US, but not in Texas. We investigated the relationship betwee...

    Authors: Julie E. Goodman, Ke Zu, Christine T. Loftus, Ge Tao, Xiaobin Liu and Sabine Lange
    Citation: Asthma Research and Practice 2017 3:6
  3. Prior evidence suggests that vitamin D deficiency may increase the risk of asthma and atopy and impair pulmonary function in children.

    Authors: Suzanne L. Pollard, John J. Lima, Karina Romero, Carla Tarazona-Meza, Edward Mougey, Katherine Tomaino, Gary Malpartida-Guzmán, Nadia N. Hansel and William Checkley
    Citation: Asthma Research and Practice 2017 3:5
  4. Asthma, a chronic respiratory disease affecting over 18.7 million American adults, has marked disparities by gender, race/ethnicity and socioeconomic status. Our goal was to identify gender-specific demographi...

    Authors: Rebecca Greenblatt, Omar Mansour, Edward Zhao, Michelle Ross and Blanca E Himes
    Citation: Asthma Research and Practice 2017 3:2
  5. In recent decades, both asthma prevalence and incidence have been increasing worldwide, not only due to the genetic background, but mainly because of the effect of a wide number of environmental and lifestyle ...

    Authors: Carlos Nunes, Ana Margarida Pereira and Mário Morais-Almeida
    Citation: Asthma Research and Practice 2017 3:1
  6. Food allergic individuals are exposed to unnecessary dietary restrictions due to precautionary food allergy labelling (PFAL). Two forms of PFAL exist: type I identifies the possible presence of allergenic cont...

    Authors: Alessandro Fiocchi, Lamia Dahdah, Carla Riccardi, Oscar Mazzina and Vincenzo Fierro
    Citation: Asthma Research and Practice 2016 2:13
  7. Evidence that enables us to identify, assess, and access the small airways in asthma and chronic obstructive pulmonary disease (COPD) has led INTERASMA (Global Asthma Association) and WAO to take a position on...

    Authors: F. Braido, N. Scichilone, F. Lavorini, O. S. Usmani, L. Dubuske, L. P. Boulet, R. Mosges, C. Nunes, M. Sánchez-Borges, I. J. Ansotegui, M. Ebisawa, F. Levi-Schaffer, L. J Rosenwasser, J. Bousquet, T. Zuberbier and G. Walter Canonica
    Citation: Asthma Research and Practice 2016 2:12
  8. Asthma is still a major public health problem in most countries; new strategies to better control this disease are necessary. Such strategies must include predisposing factors. One of these factors is smoking ...

    Authors: José Miguel Chatkin and Cynthia Rocha Dullius
    Citation: Asthma Research and Practice 2016 2:10
  9. Molecular based in vitro technologies greatly changed the diagnostic approaches in allergy. At present, sensitization profiles can be dissected according to IgE subsets, which are specific for genuine or cross...

    Authors: Giovanni Melioli, Eleonora Savi, Maria Angiola Crivellaro and Giovanni Passalacqua
    Citation: Asthma Research and Practice 2016 2:9
  10. Asthma management in Australia is suboptimal. The “Guidelines for provision of a Pharmacist Only medicine: short acting beta agonists” (SABA guidelines) and a novel West Australian “Asthma Action Plan card” (AAP ...

    Authors: Kim Watkins, Colleen Fisher, Jila Misaghian, Carl R. Schneider and Rhonda Clifford
    Citation: Asthma Research and Practice 2016 2:8
  11. Asthma is a disease encompassing a variety of contributing factors. Phenotyping of asthma based on the profile of accumulated granulocytes in the airways has been performed to explore the mediators involved in...

    Authors: Yotaro Takaku, Tomoyuki Soma, Yoshitaka Uchida, Takehito Kobayashi, Kazuyuki Nakagome and Makoto Nagata
    Citation: Asthma Research and Practice 2016 2:6
  12. In the present review, we focus on evidence-based data for the use of inhaled corticosteroids (ICS), leukotriene receptor antagonist (LTRA), long-acting beta2-agonits (LABA) and oral corticosteroids (OCS), wit...

    Authors: Jose A. Castro-Rodriguez, Adnan Custovic and Francine M. Ducharme
    Citation: Asthma Research and Practice 2016 2:5
  13. Fluticasone furoate (FF)/vilanterol (VI) is a once-daily inhaled corticosteroid (ICS)/long-acting beta2 agonist (LABA) combination. FF/VI, 92/22mcg and 184/22mcg, are approved in Europe as maintenance therapy in ...

    Authors: Henrik Svedsater, Gillian Stynes, Jaro Wex, Lucy Frith, David Leather, Emanuela Castelnuovo, Michelle Detry and Scott Berry
    Citation: Asthma Research and Practice 2016 2:4
  14. Asthma affects a significant proportion of elderly patients, but unfortunately, it is responsible for a high asthma-related morbidity and mortality in this population. This may be related not only to the devel...

    Authors: Louis-Philippe Boulet
    Citation: Asthma Research and Practice 2016 2:3
  15. Historically, asthma has been envisioned as a disease of younger ages. This has led to the assumption that respiratory symptoms suggestive of asthma occurring in older ages are to be attributed to conditions o...

    Authors: Alida Benfante and Nicola Scichilone
    Citation: Asthma Research and Practice 2016 2:2
  16. In asthma, exacerbations and poor disease control are linked to airway allergic inflammation. Serum periostin has been proposed as a systemic biomarker of eosinophilic inflammation. This pilot study aims at ev...

    Authors: N. Scichilone, C. Crimi, A. Benfante, S. Battaglia, M. Iemmolo, M. Spatafora and N. Crimi
    Citation: Asthma Research and Practice 2016 2:1
  17. Sickle cell disease (SCD) is the most common life-limiting genetic disease among African Americans, affecting more than 100,000 people in the United States. Respiratory disorders in patients with sickle cell d...

    Authors: Robyn T. Cohen, Elizabeth S. Klings and Robert C. Strunk
    Citation: Asthma Research and Practice 2015 1:14
  18. Multiple factors interact to trigger allergic diseases, including individual genetic background and factors related to the environment such as exposure to allergens, air pollution and respiratory infections. T...

    Authors: Cintia Rodrigues Marques, Ryan Santos Costa, Gustavo Nunes de Oliveira Costa, Thiago Magalhães da Silva, Tatiane Oliveira Teixeira, Emília Maria Medeiros de Andrade, Alana A. Galvão, Valdirene Leão Carneiro and Camila Alexandrina Figueiredo
    Citation: Asthma Research and Practice 2015 1:10
  19. In this article, we discuss the relationship between environmental exposures within the school environment and pediatric asthma morbidity. This article will conclude by reviewing novel school based asthma educ...

    Authors: Marissa Hauptman and Wanda Phipatanakul
    Citation: Asthma Research and Practice 2015 1:12
  20. Involving patients and the public in research prioritisation is important. Cochrane Airways works with authors to produce systematic reviews of evidence related to chronic airways disease. Cochrane Airways has...

    Authors: Rebecca Normansell and Emma Welsh
    Citation: Asthma Research and Practice 2015 1:11
  21. Vocal cord dysfunction (VCD) is a term that refers to inappropriate adduction of the vocal cords during inhalation and sometimes exhalation. It is a functional disorder that serves as an important mimicker of ...

    Authors: Neha M. Dunn, Rohit K. Katial and Flavia C. L. Hoyte
    Citation: Asthma Research and Practice 2015 1:9
  22. Despite the regular treatment with inhaled corticosteroids (ICS) or ICS plus long-acting beta2-agonists, permits to control de majority of asthmatics, a significant proportion of patients does not respond to t...

    Authors: Ilaria Baiardini, Francesca Sicuro, Francesco Balbi, Giorgio Walter Canonica and Fulvio Braido
    Citation: Asthma Research and Practice 2015 1:7
  23. The use and role of allergen immunotherapy (AIT) in asthma is still a matter of debate, and no definite recommendation about this is made in guidelines, both for the subcutaneous and sublingual routes. This is...

    Authors: Giovanni Passalacqua, Anthi Rogkakou, Marcello Mincarini and Giorgio Walter Canonica
    Citation: Asthma Research and Practice 2015 1:6
  24. In the practical management of allergic rhinitis (AR), pharmacists are usually the first-line contact, also because some medications are available as over the counter. Therefore, pharmacists may represent an i...

    Authors: Carlo Lombardi, Eleonora Musicco, Francesco Rastrelli, Germano Bettoncelli, Giovanni Passalacqua and Giorgio Walter Canonica
    Citation: Asthma Research and Practice 2015 1:4
  25. Patients with cystic fibrosis (CF) complicated by allergic bronchopulmonary aspergillosis (ABPA) are vitamin D deficient and in vitro treatment with 1,25 (OH)2 vitamin D3 of CD4+ cells from CF patients with ABPA ...

    Authors: Nikki Lynn Hue Nguyen, Joseph M. Pilewski, Juan C. Celedón, Sivanarayana Mandalapu, Megan L. Blanchard, Adrienne DeRicco, Elizabeth Hartigan, John F. Alcorn and Jay K. Kolls
    Citation: Asthma Research and Practice 2015 1:3
  26. Obesity is the most common asthma co-morbidity; it has been associated with increased risk for asthma exacerbations, worse respiratory symptoms and poor control. The exact mechanisms remain elusive and are pro...

    Authors: Cynthia Wilson Baffi, Daniel Efrain Winnica and Fernando Holguin
    Citation: Asthma Research and Practice 2015 1:1

Annual Journal Metrics

  • Speed
    20 days to first decision for all manuscripts (Median)
    62 days to first decision for reviewed manuscripts only (Median)

    Usage 
    109,568 Downloads (2021)
    213 Altmetric mentions (2021)